Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ephedra Sales Ban Gains Congressional Momentum Following Athlete’s Death

Feb 24 2003

• By The Tan Sheet

Related Content

Durbin DSHEA Reform To Focus On Mandatory AERs, Labeling Accuracy

Jan 20 2003

Ephedra Weight-Loss Claims “Inappropriate,” FDA’s Crawford Says

Oct 14 2002

Ephedra OTC Drug Status Consideration Floated By AHPA’s McGuffin

Dec 16 2002

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window